8 research outputs found
Impact of nutrition on non-coding RNA epigenetics in breast and gynecological cancer
Cancer is the second leading cause of death in females. According to the American
Cancer Society, there are 327,660 new cases in breast and gynecological cancers
estimated in 2014, placing emphasis on the need for cancer prevention and new cancer
treatment strategies. One important approach to cancer prevention involves phytochemicals,
biologically active compounds derived from plants. A variety of studies on the
impact of dietary compounds found in cruciferous vegetables, green tea, and spices like
curry and black pepper have revealed epigenetic changes in female cancers. Thus, an
important emerging topic comprises epigenetic changes due to the modulation of noncoding
RNA levels. Since it has been shown that non-coding RNAs such as microRNAs
and long non-coding RNAs are aberrantly expressed in cancer, and furthermore are
linked to distinct cancer phenotypes, understanding the effects of dietary compounds and
supplements on the epigenetic modulator non-coding RNA is of great interest. This article
reviews the current findings on nutrition-induced changes in breast and gynecological
cancers at the non-coding RNA level
Impact of nutrition on non-coding RNA epigenetics in breast and gynecological cancer
Cancer is the second leading cause of death in females. According to the American
Cancer Society, there are 327,660 new cases in breast and gynecological cancers
estimated in 2014, placing emphasis on the need for cancer prevention and new cancer
treatment strategies. One important approach to cancer prevention involves phytochemicals,
biologically active compounds derived from plants. A variety of studies on the
impact of dietary compounds found in cruciferous vegetables, green tea, and spices like
curry and black pepper have revealed epigenetic changes in female cancers. Thus, an
important emerging topic comprises epigenetic changes due to the modulation of noncoding
RNA levels. Since it has been shown that non-coding RNAs such as microRNAs
and long non-coding RNAs are aberrantly expressed in cancer, and furthermore are
linked to distinct cancer phenotypes, understanding the effects of dietary compounds and
supplements on the epigenetic modulator non-coding RNA is of great interest. This article
reviews the current findings on nutrition-induced changes in breast and gynecological
cancers at the non-coding RNA level
Impact of nutrition on non-coding RNA epigenetics in breast and gynecological cancer
Cancer is the second leading cause of death in females. According to the American
Cancer Society, there are 327,660 new cases in breast and gynecological cancers
estimated in 2014, placing emphasis on the need for cancer prevention and new cancer
treatment strategies. One important approach to cancer prevention involves phytochemicals,
biologically active compounds derived from plants. A variety of studies on the
impact of dietary compounds found in cruciferous vegetables, green tea, and spices like
curry and black pepper have revealed epigenetic changes in female cancers. Thus, an
important emerging topic comprises epigenetic changes due to the modulation of noncoding
RNA levels. Since it has been shown that non-coding RNAs such as microRNAs
and long non-coding RNAs are aberrantly expressed in cancer, and furthermore are
linked to distinct cancer phenotypes, understanding the effects of dietary compounds and
supplements on the epigenetic modulator non-coding RNA is of great interest. This article
reviews the current findings on nutrition-induced changes in breast and gynecological
cancers at the non-coding RNA level
Increased lanosterol turnover : a metabolic burden for daunorubicin-resistant leukemia cells
The cholesterol metabolism is essential for cancer cell proliferation. We found the expression of genes involved in the cholesterol biosynthesis pathway up-regulated in the daunorubicin-resistant leukemia cell line CEM/R2, which is a daughter cell line to the leukemia cell line CCRF-CEM (CEM). Cellular (H2O)-H-2 labelling, mass spectrometry, and isotopomer analysis revealed an increase in lanosterol synthesis which was not accompanied by an increase in cholesterol flux or pool size in CEM/R2 cells. Exogenous addition of lanosterol had a negative effect on CEM/R2 and a positive effect on sensitive CEM cell viability. Treatment of CEM and CEM/R2 cells with cholesterol biosynthesis inhibitors acting on the enzymes squalene epoxidase and lanosterol synthase, both also involved in the 24,25-epoxycholesterol shunt pathway, revealed a connection of this pathway to lanosterol turnover. Our data highlight that an increased lanosterol flux poses a metabolic weakness of resistant cells that potentially could be therapeutically exploited
Increased lanosterol turnover : a metabolic burden for daunorubicin-resistant leukemia cells
The cholesterol metabolism is essential for cancer cell proliferation. We found the expression of genes involved in the cholesterol biosynthesis pathway up-regulated in the daunorubicin-resistant leukemia cell line CEM/R2, which is a daughter cell line to the leukemia cell line CCRF-CEM (CEM). Cellular (H2O)-H-2 labelling, mass spectrometry, and isotopomer analysis revealed an increase in lanosterol synthesis which was not accompanied by an increase in cholesterol flux or pool size in CEM/R2 cells. Exogenous addition of lanosterol had a negative effect on CEM/R2 and a positive effect on sensitive CEM cell viability. Treatment of CEM and CEM/R2 cells with cholesterol biosynthesis inhibitors acting on the enzymes squalene epoxidase and lanosterol synthase, both also involved in the 24,25-epoxycholesterol shunt pathway, revealed a connection of this pathway to lanosterol turnover. Our data highlight that an increased lanosterol flux poses a metabolic weakness of resistant cells that potentially could be therapeutically exploited
Evolutionary analyses reveal immune cell receptor GPR84 as a conserved receptor for bacteria-derived molecules
The G protein-coupled receptor 84 (GPR84) is found in immune cells and its expression is increased under inflammatory conditions. Activation of GPR84 by medium-chain fatty acids results in pro-inflammatory responses. Here, we screened available vertebrate genome data and found that GPR84 is present in vertebrates for more than 500 million years but absent in birds and a pseudogene in bats. Cloning and functional characterization of several mammalian GPR84 orthologs in combination with evolutionary and model-based structural analyses revealed evidence for positive selection of bear GPR84 orthologs. Naturally occurring human GPR84 variants are most frequent in Asian populations causing a loss of function. Further, we identified cis- and trans-2-decenoic acid, both known to mediate bacterial communication, as evolutionary highly conserved ligands. Our integrated set of approaches contributes to a comprehensive understanding of GPR84 in terms of evolutionary and structural aspects, highlighting GPR84 as a conserved immune cell receptor for bacteria-derived molecules